In the CORE list of outbreaks and adverse events as of October 5, 2022, for the Salmonella Litchfield outbreak in a not yet identified product (reference #1105), the case count has increased from 28 cases to 29 cases. For the E. coli O157:H7 outbreak (reference #1081) in a not yet identified product, CDC announced the outbreak was over on 10/4/2022. FDA’s investigation is ongoing. For the Listeria monocytogenes outbreak in Brie and Camembert cheese (reference #1106), an outbreak advisory was issued on 9/30/2022. One additional case was added for the Salmonella Typhimurium outbreak (reference #1095), and the product linked to illnesses has been changed to cantaloupe. The vehicle of the outbreak was confirmed after the outbreak ended. Given the product(s) were no longer on the market, there was no ongoing risk to public health and no need to avoid eating cantaloupe. Additional information on this outbreak will be forthcoming. The outbreak of Cyclospora cayetanensis in a not yet identified product (reference #1080), the case count has increased from 81 to 84 and the outbreak has ended. For the outbreak of Cyclospora cayetanensis in a not yet identified product (reference #1084), the outbreak has ended. For Listeria monocytogenes adverse event in a not identified product (reference #1040), the outbreak has ended. @ https://www.fda.gov/food/outbreaks-foodborne-illness/investigations-foodborne-illness-outbreaks?utm_medium=email&utm_source=govdelivery
Core update October 5, 2022
Investigations of Foodborne Illness Outbreaks
The following is a list of outbreak and adverse event investigations primarily being managed by FDA’s CORE Response Teams.
No comments